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Female sterilization, typically accomplished by means of 
tubal ligation, is a widely used 
method of contraception that is 
highly effective at preventing un-
intended pregnancy. Yet there ap-
pears to be unmet demand for 
the procedure in certain segments 
of the U.S. population.1 Specifi-
cally, low-income women and 
women from minority racial and 
ethnic groups may face substan-
tial system-level barriers to ob-
taining a desired sterilization pro-
cedure.1 One such barrier is the 
federal policy regarding Medicaid-
funded sterilizations. Although 
this policy was designed to pro-
tect vulnerable populations, we 
believe that it does not effectively 
fulfill that intention — in fact, it 
restricts the reproductive autono-
my of the women it intends to 
serve. With the upcoming Medic-
aid expansions, the number of 
women affected by these barriers 
could increase substantially.
The use of tubal ligation as a 
contraceptive method increased 
dramatically during the 1960s 
and 1970s with the legalization 
of contraception, improved safety 
of laparoscopic techniques, and 
the creation of federally funded 
family-planning programs that 
subsidized the costs. During those 
years, numerous reports of coer-
cive and nonconsensual steriliza-
tion of minority and poor women 
emerged, inciting a public out-
cry in which the government was 
accused of racist and classist ap-
plications of family-planning pro-
grams. In response, in 1976, the 
Department of Health, Education, 
and Welfare developed protective 
regulations and a standardized 
consent form for publicly funded 
sterilization procedures. These 
regulations pro hibited sterilization 
of persons younger than 21 years 
of age or who were mentally in-
competent or institutionalized. 
They also required a 72-hour 
waiting period before steriliza-
tion; in 1978, the waiting period 
was extended to 30 days from 
the time of written informed 
consent. Although these regula-
tions apply to both women and 
men, female sterilization is sig-
nificantly more common than 
male sterilization in low-income 
populations, and women often 
desire sterilization at a specific 
time — after childbirth — which 
makes the extended waiting pe-
riod particularly problematic.
Because these policies have not 
changed since 1978, women re-
questing publicly funded steril-
ization must complete the “Con-
sent to Sterilization” section of 
the Medicaid Title XIX form (Title 
XIX-SCF) at least 30 days and no 
more than 180 days before un-
dergoing the procedure. In addi-
tion, a signed copy of the con-
sent form must be available or 
verified at the time of the proce-
dure. If the woman is undergo-
ing emergency abdominal sur-
gery or a premature delivery, the 
30-day waiting period may be 
waived, but at least 72 hours 
must have elapsed between the 
consent and the procedure.
Although the policy was pre-
sumably well intentioned, there is 
evidence that the Medicaid con-
sent process may not be capable 
of protecting vulnerable women 
by ensuring that truly informed 
consent is obtained. Although the 
consent form contains language 
designed to confirm the wom-
an’s understanding of the risks 
and benefits of the procedure, 
including the fact that the result 
is permanent, as well as infor-
mation about the mandatory 30-
day waiting period, assessments 
of the form’s readability indicate 
that it is overly complicated and 
its literacy level is too high for 
the average American adult.2 In 
one study assessing women’s 
knowledge about sterilization af-
ter they had been given the Med-
icaid consent form for review, 
more than one third of respon-
dents (34%) answered incorrectly 
when asked about the permanence 
of sterilization.3 When a modified, 
low-literacy version of Title XIX-
SCF was compared with the cur-
rent form in a randomized trial 
involving 200 women with Medic-
aid coverage, those who reviewed 
the modified form were more 
likely to know about the 30-day 
waiting period before the form is 
considered valid (a 24-percentage-
point difference between groups), 
that nonpermanent contraceptive 
options as effective as sterilization 
are available (an 8-percentage-point 
difference), and that the procedure 
is permanent (a 16-percentage-
point difference).3
Beyond concerns about the 
consent form, the waiting period 
and the need for the completed 
form to be transferred to the de-
livery unit pose logistic barriers 
for women who wish to undergo 
tubal ligation immediately after 
giving birth. Currently, among U.S. 
women sterilized within 2 years 
after delivery, more than 70% of 
procedures are done in the imme-
diate postpartum period. Women 
report that requesting sterilization 
too late in pregnancy to fulfill 
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the 30-day waiting period, not hav-
ing the form present at the time 
of delivery, or delivering before 
the mandatory waiting period had 
elapsed prevented them from 
having their request for steriliza-
tion fulfilled at the time of deliv-
ery.1 Moreover, because women 
with private insurance are not 
subject to the same regulations, 
the policy creates a two-tiered 
system of access, in which low-
income women may not be able 
to exercise the same degree of 
reproductive autonomy as their 
wealthier counterparts. Inequitable 
access is compounded by the fact 
that many Medicaid beneficiaries 
who do not receive a desired 
sterilization during the immedi-
ate postpartum period may miss 
their window of opportunity, since 
pregnancy-related Medicaid eligi-
bility ends shortly after delivery. 
These issues recently prompted 
the American College of Obstet-
rics and Gynecology Committee 
on Health Care for Underserved 
Women to recommend revising 
Medicaid policy to create fair and 
equitable access to sterilization 
procedures.1
Preventing women from ob-
taining a desired sterilization 
puts them at high risk for unin-
tended pregnancy. In one study, 
47% of women who requested 
but did not receive a postpartum 
sterilization became pregnant dur-
ing the first year after delivery — 
over twice the rate of pregnancies 
in women who did not request 
sterilization.4 Unfortunately, un-
intended pregnancy remains a 
prevalent and substantial issue 
in the United States, since such 
pregnancies are associated with 
numerous adverse health and so-
cial consequences for women 
and their families. In addition, 
unintended pregnancy is costly 
for society, with direct annual 
public costs of billions of dol-
lars. Reducing barriers associat-
ed with Medicaid policy regard-
ing sterilization may be one 
approach to making a dent in 
the stubbornly high rate of un-
intended pregnancy and the high 
costs associated with it. In a re-
cent cost analysis, we found that 
Medicaid-policy–related barriers 
lead to approximately 62,000 un-
fulfilled requests for postpartum 
sterilization annually, resulting 
in an estimated 10,000 abortions 
and 19,000 unintended births in 
the subsequent year, at a public 
cost of $215 million (see chart).5
Discussions about modifying 
federal policy on sterilization 
need to be thoughtful and sensi-
tive to the fact that there is a 
larger social and historical con-
text in which the reproductive 
behavior of low-income and mi-
nority women has commonly been 
negatively stereotyped and their 
fertility less valued than that of 
other women. Unfortunately, as 
recent allegations that nearly 150 
incarcerated women in California 
underwent coercive sterilizations 
between 2006 and 2010 attest, 
protection for vulnerable women 
is still needed. However, given 
the high rate of unintended preg-
nancy, enhancing access to each 
woman’s contraceptive method of 
choice is also critical. An ideal 
Medicaid policy or process would 
strive to meet these two goals by 
ensuring patient comprehension 
and facilitating access to steril-
ization for women who have 
made an informed decision to 
undergo the procedure.
To this end, we believe that 
the current Medicaid Title XIX 
sterilization consent form needs 
to be either redesigned, in order 
to present the pertinent informa-
tion in an easier-to-read, user-
friendly format, or ideally re-
placed altogether by a validated 
decision-support tool that can 
more effectively ensure an in-
formed decision-making process. 
Outcomes of Postpartum
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Estimated Annual Number of Requests for Postpartum Sterilization That Go Unfulfilled 
Because of Medicaid Policy Barriers, and Unintended Pregnancies in the Subsequent Year.
The pie chart shows the outcomes of the estimated 255,000 requests for federally funded, 
postpartum sterilizations made each year. In the subsequent year, an estimated 29,000 
un intended pregnancies will occur among the 62,000 women with sterilization requests 
that are unfulfilled because of Medicaid policy barriers, costing taxpayers $215 million 
annually. Estimates are based on a cost-analysis model described in Borrero et al.5
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In addition, we believe that the 
30-day mandatory waiting period 
is excessive and should be short-
ened considerably or eliminated 
— a change that could also ad-
dress the problem of failed trans-
fer of the completed federal doc-
ument to the delivery unit.
Although the principles behind 
the Medicaid policy remain rele-
vant, it is in dire need of mod-
ification. Measures to promote 
informed decision making regard-
ing sterilization, rather than strin-
gent and restrictive regulations, 
can simultaneously protect vulner-
able populations and allow women 
to reduce their risk of unintended 
pregnancy. Thus, revisiting and 
amending sterilization policy rep-
resents an opportunity to honor 
women’s reproductive autonomy, 
create more equitable access to 
sterilization, save a substantial 
amount of health care dollars, and 
prevent unintended pregnancy.
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Mom at Bedside, Appears Calm
Suzanne Koven, M.D.
We carry a nylon lunch bag everywhere we go, royal 
blue with purple trim, containing 
two plastic syringes, each preload-
ed with 5 mg of liquid Valium, 
plus packets of surgical lubricant 
and plastic gloves. At the first 
sign of blinking or twitching, we 
lay him on his left side, tug down 
the elastic waist of his pants, part 
his small buttocks, and insert 
the gooped-up tip. Within mo-
ments, the motion stops, as if 
an engine has been switched off. 
Then he falls into a deep sleep. 
When he relaxes, so do we.
He’s 5 years old, the first time. 
Our babysitter takes him to a 
pizza place for lunch. He laughs 
mid-slice, blinks his eyes several 
times, slumps to the floor, and 
climbs back onto his chair. She 
hesitates — what was that? — 
and then calls 911. She pages me. 
I keep the message stored in my 
beeper, periodically daring myself 
to relive my first reading of it.
I meet them in the ER at the 
community hospital near our 
home, showily flashing my down-
town hospital ID tag. Soon my 
husband rushes in, wearing the 
ID from his downtown hospital. 
All the tests are negative, they 
say. Bring him back if something 
else happens.
Something else happens. The 
next day, I skip work and keep 
him home from school. He sits 
happily in front of cartoons while 
I pace and polish, pace and fold. 
Maybe the babysitter overreacted, 
I reason. Maybe he’s just a goofy 
kid. The moment I stop watching 
him, he cries, “Look, Mommy! 
Look what my hand can do!”
Downtown. No mistaking it 
this time. Grand mal, big and 
bad, right on the gurney. Lumbar 
puncture. MRI. All negative. Be-
fore we go home, the neurologist 
asks if we have further questions. 
“Just one,” I say. “What do we do 
if he does it again?” The neurolo-
gist seems surprised. His raised 
eyebrows silently ask, “Aren’t you 
both doctors?” He hands us a 
pamphlet.
Dilantin. Chewable yellow tri-
angles three times a day. Trian-
gles to first grade and the beach 
and day camp and a sleepover. 
The other kid has cochlear im-
plants. “Don’t worry,” his mother 
says, accepting my baggie of pills. 
“My kid comes with instructions, 
too.” We become members of 
an exclusive club no one wants 
to join.
One day, almost exactly a year 
later, the school nurse calls. “It’s 
been 10 minutes and it’s not 
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